{"version":"1.0","provider_name":"BIG FOUR Pharmaceutical Pricing Boot Camp","provider_url":"https:\/\/www.americanconference.com\/big-four-pharmaceutical-pricing","title":"Workshop B &mdash; Federal Government Market Access Working Group: A Guide to Optimizing Revenue and Creating Federal-Specific Value to the Big Four Agencies | BIG FOUR Pharmaceutical Pricing Boot Camp","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"qYkD9654to\"><a href=\"https:\/\/www.americanconference.com\/big-four-pharmaceutical-pricing\/workshops\/workshop-b\/\">Workshop B &mdash; Federal Government Market Access Working Group: A Guide to Optimizing Revenue and Creating Federal-Specific Value to the Big Four Agencies<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.americanconference.com\/big-four-pharmaceutical-pricing\/workshops\/workshop-b\/embed\/#?secret=qYkD9654to\" width=\"600\" height=\"338\" title=\"&#8220;Workshop B &mdash; Federal Government Market Access Working Group: A Guide to Optimizing Revenue and Creating Federal-Specific Value to the Big Four Agencies&#8221; &#8212; BIG FOUR Pharmaceutical Pricing Boot Camp\" data-secret=\"qYkD9654to\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.americanconference.com\/big-four-pharmaceutical-pricing\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","description":"This post-conference workshop will explore what drug manufacturers can do to ensure Federal-specific value creation and optimize revenue by looking beyond statutory contracting and pricing into the full range of levers manufacturers can use to successfully launch products in Federal Agency Health Systems. Topics of discussion will include: Market Access Levers in the VA and&hellip;","thumbnail_url":"https:\/\/www.americanconference.com\/big-four-pharmaceutical-pricing\/wp-content\/uploads\/sites\/1999\/2026\/03\/899L26_linkedin_general.jpg","thumbnail_width":1200,"thumbnail_height":1200}